Canadian Society of Nephrology Commentary on the 2012 KDIGO Clinical Practice Guideline for the Management of Blood Pressure in CKD

2014 ◽  
Vol 63 (6) ◽  
pp. 869-887 ◽  
Author(s):  
Marcel Ruzicka ◽  
Robert R. Quinn ◽  
Phil McFarlane ◽  
Brenda Hemmelgarn ◽  
G.V. Ramesh Prasad ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Clinical Practice ◽  
Clinical Practice Guideline ◽  
Practice Guideline ◽  
Canadian Society

scholarly journals Canadian Society of Nephrology Commentary on the KDIGO Clinical Practice Guideline for CKD Evaluation and Management

2015 ◽  
Vol 65 (2) ◽  
pp. 177-205 ◽  
Author(s):  
Ayub Akbari ◽  
Catherine M. Clase ◽  
Phil Acott ◽  
Marisa Battistella ◽  
Aminu Bello ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Clinical Practice Guideline ◽  
Practice Guideline ◽  
Canadian Society

Canadian Society of Nephrology Commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD

2013 ◽  
Vol 62 (5) ◽  
pp. 860-873 ◽  
Author(s):  
Louise M. Moist ◽  
Stéphan Troyanov ◽  
Colin T. White ◽  
Lori D. Wazny ◽  
Jo-Anne Wilson ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Clinical Practice Guideline ◽  
Practice Guideline ◽  
Canadian Society

scholarly journals Canadian Society of Transplantation and Canadian Society of Nephrology Commentary on the 2017 KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors

2020 ◽  
Vol 7 ◽  
pp. 205435812091845
Author(s):  
Ngan N. Lam ◽  
Christine Dipchand ◽  
Marie-Chantal Fortin ◽  
Bethany J. Foster ◽  
Anand Ghanekar ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Clinical Practice Guideline ◽  
Practice Guideline ◽  
Assessment Tools ◽  
Canadian Society ◽  
Sources Of Information ◽  
Kidney Donors ◽  
Living Kidney Donors ◽  
Kidney Paired Donation ◽  
Donor Population

Purpose of review: To review an international guideline on the evaluation and care of living kidney donors and provide a commentary on the applicability of the recommendations to the Canadian donor population. Sources of information: We reviewed the 2017 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors and compared this guideline to the Canadian 2014 Kidney Paired Donation (KPD) Protocol for Participating Donors. Methods: A working group was formed consisting of members from the Canadian Society of Transplantation and the Canadian Society of Nephrology. Members were selected to have representation from across Canada and in various subspecialties related to living kidney donation, including nephrology, surgery, transplantation, pediatrics, and ethics. Key findings: Many of the KDIGO Guideline recommendations align with the KPD Protocol recommendations. Canadian researchers have contributed to much of the evidence on donor evaluation and outcomes used to support the KDIGO Guideline recommendations. Limitations: Certain outcomes and risk assessment tools have yet to be validated in the Canadian donor population. Implications: Living kidney donors should be counseled on the risks of postdonation outcomes given recent evidence, understanding the limitations of the literature with respect to its generalizability to the Canadian donor population.

Impact of the 2017 American Academy of Pediatrics’ Clinical Practice Guideline on the Identification and Risk Stratification of Youth at Increased Cardiovascular Disease Risk

Hypertension ◽  
2021 ◽  
Author(s):  
Tammy M. Brady ◽  
Kathleen Altemose ◽  
Elaine M. Urbina
Keyword(s):  
Blood Pressure ◽  
Cardiovascular Disease ◽  
Clinical Practice ◽  
Risk Stratification ◽  
American Academy ◽  
Clinical Practice Guideline ◽  
Practice Guideline ◽  
Disease Risk ◽  
Cardiovascular Disease Risk ◽  
American Academy Of Pediatrics

The updated clinical practice guideline (CPG) published by the American Academy of Pediatrics in 2017 introduced significant changes to the diagnostic and evaluative approach towards children with elevated blood pressure. The goals of this review were to summarize the current evidence regarding the impact of the new CPG on the identification and risk stratification of children at increased cardiovascular disease risk. Universally, the new CPG definitions of abnormal blood pressure led to more children classified as having a hypertensive blood pressure when compared with alternative definitions. Youth who moved to a higher blood pressure stage with the CPG typically had worse cardiometabolic profiles and more comorbidites. The association of CPG-defined hypertension and concurrent intermediate cardiovascular disease outcomes such as left ventricular hypertrophy and increased pulse wave velocity remains unclear; however, longitudinal data suggests an improved identification of those at greatest risk for adult cardiovascular disease with the CPG definitions. The majority of studies reviewed used blood pressure from one encounter, not replicate blood pressures from multiple visits, to define an abnormal or hypertensive blood pressure. Therefore, future studies investigating the prevalence of confirmed hypertension and the association between confirmed hypertension and outcomes are needed to optimally characterize the performance of the new CPG on identifying children at cardiovascular disease risk.

Sign in / Sign up

Export Citation Format

Share Document